Abstract
CYP2C19 is an important member of the cytochrome P-450 enzyme superfamily and plays a significant role in the drug metabolism. In order to gain insights for developing personalized drugs, the structure-activity relationships of two SNPs, W120R and I331V, with the ligands of CEC, Fluvoxamine, Lescol and Ticlopidine were investigated through the structure-activity relationship approach. By means of a series of docking studies, the binding pockets of the two SNPs for the four compounds are explicitly defined that will be very useful for conducting mutagenesis studies, providing insights into personalization of drug treatments and stimulating novel strategies for finding desired personalized drugs.
Keywords: CYP2C19, Cytochrome P-450, Structure-activity relationship, CEC, Fluvoxamine, Lescol, Ticlopidine, Personalized drug design
Protein & Peptide Letters
Title: Molecular Modeling of Two CYP2C19 SNPs and Its Implications for Personalized Drug Design
Volume: 15 Issue: 1
Author(s): Dong-Qing Wei, Jing-Fang Wang, Chao Chen, Yixue Li and Kuo-Chen Chou
Affiliation:
Keywords: CYP2C19, Cytochrome P-450, Structure-activity relationship, CEC, Fluvoxamine, Lescol, Ticlopidine, Personalized drug design
Abstract: CYP2C19 is an important member of the cytochrome P-450 enzyme superfamily and plays a significant role in the drug metabolism. In order to gain insights for developing personalized drugs, the structure-activity relationships of two SNPs, W120R and I331V, with the ligands of CEC, Fluvoxamine, Lescol and Ticlopidine were investigated through the structure-activity relationship approach. By means of a series of docking studies, the binding pockets of the two SNPs for the four compounds are explicitly defined that will be very useful for conducting mutagenesis studies, providing insights into personalization of drug treatments and stimulating novel strategies for finding desired personalized drugs.
Export Options
About this article
Cite this article as:
Wei Dong-Qing, Wang Jing-Fang, Chen Chao, Li Yixue and Chou Kuo-Chen, Molecular Modeling of Two CYP2C19 SNPs and Its Implications for Personalized Drug Design, Protein & Peptide Letters 2008; 15 (1) . https://dx.doi.org/10.2174/092986608783330305
DOI https://dx.doi.org/10.2174/092986608783330305 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development
Pharmaceutical Nanotechnology Imidazoles and Benzimidazoles as Tubulin-Modulators for Anti-Cancer Therapy
Current Medicinal Chemistry Differences Among Sexes in Blood Pressure: A Combinatorial Consequence of the Differences between RAAS Components, Sex Hormones, and Time Course
Current Hypertension Reviews A Probabilistic Analysis About the Concepts of Difficulty and Usefulness of a Molecular Ranking Classification
Current Computer-Aided Drug Design The Effects of Current Therapies on Airway Remodeling in Asthma and New Possibilities for Treatment and Prevention
Current Molecular Pharmacology The Role of Intracrine Androgen Metabolism, Androgen Receptor and Apoptosis in the Survival and Recurrence of Prostate Cancer During Androgen Deprivation Therapy
Current Drug Targets Rate-Determining and Rate-Limiting Steps in the Clearance and Excretion of a Potent and Selective p21-Activated Kinase Inhibitor: A Case Study of Rapid Hepatic Uptake and Slow Elimination in Rat
Drug Metabolism Letters Assessment of Chemicals Applying Partial Order Ranking Techniques
Combinatorial Chemistry & High Throughput Screening Novel 4-bromo-2-(3-methyl-1-(substituted-phenylsulfonyl)-4,5-dihydro-1- H-pyrazol-5-yl)phenol Derivatives: Synthesis and Antibacterial Activity
Letters in Drug Design & Discovery An Edge Preservation Index for Evaluating Nonlinear Spatial Restoration in MR Images
Current Medical Imaging Methylene Blue and Vasoplegia: Who, When, and How?
Mini-Reviews in Medicinal Chemistry Recent Advances in Small Molecule Inhibitors of VEGFR and EGFR Signaling Pathways
Current Topics in Medicinal Chemistry Discovery of GPCR Ligands by Molecular Docking Screening: Novel Opportunities Provided by Crystal Structures
Current Topics in Medicinal Chemistry The Chemistry of Mycophenolic Acid - Synthesis and Modifications Towards Desired Biological Activity
Current Medicinal Chemistry Screening of Phytoconstituents from Traditional Plants against SARSCoV- 2 using Molecular Docking Approach
Letters in Drug Design & Discovery Virus Attachment and Entry Offer Numerous Targets for Antiviral Therapy
Current Pharmaceutical Design Recent Advances in Stearoyl-CoA Desaturase 1 Inhibitors for Dyslipidemia and Obesity
Current Topics in Medicinal Chemistry Zwittermicin A: A Promising Aminopolyol Antibiotic from Biocontrol Bacteria
Current Organic Chemistry CypD: The Key to the Death Door
CNS & Neurological Disorders - Drug Targets Fetal Risks of Maternal Diabetes
Current Women`s Health Reviews